Asia's Ascent — Global Trends in Biomedical R&D Expenditures
- 2 January 2014
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 370 (1), 3-6
- https://doi.org/10.1056/nejmp1311068
Abstract
In recent years, industry has reduced its investment in U.S. biomedical research and development by billions of dollars, while increasing investment in Asia–Oceania. Thus, boosting U.S. government funding alone may be inadequate for retaining long-term R&D leadership.Keywords
This publication has 4 references indexed in Scilit:
- The Calculus of National Medical Research Policy — The United States versus AsiaNew England Journal of Medicine, 2012
- What Are The Respective Roles Of The Public And Private Sectors In Pharmaceutical Innovation?Health Affairs, 2011
- The cost of drug development: A systematic reviewHealth Policy, 2011
- Funding of US Biomedical Research, 2003-2008JAMA, 2010